Not sure how you drew this conclusion from wording of this paragraph.
The paragraph says 'it intends to meet with the FDA...' - which means it hasn't as yet.
The paragraph also says 'Concurrently, MSB will also explore potential strategic initiatives...' - which means they haven't as yet.
Therefore, it appears nobody is currently in CHF discussion with MSB.
I actually find this hard to believe if this were actually true. The wording doesn't lie.
Ann: Appendix 4C Quarterly Activity Report, page-91
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |